Le Propriété institutionnelle de Amarin Corp est 35.29%
La propriété institutionnelle est le montant des actions disponibles d'une société détenues par des fonds mutuels ou des fonds de pension, des compagnies d'assurance, des sociétés d'investissement, des fonds de dotation ou d'autres grandes entités qui gèrent des fonds pour le compte de tiers.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.